#United States #New York #Monteverde #Longevity Health #XAGE

Investigation into Merger of Longevity Health Holdings, Inc.

On April 14, 2025, Monteverde & Associates PC, a notable law firm specializing in class action lawsuits, disclosed its investigation into the proposed merger of Longevity Health Holdings, Inc. (NASDAQ: XAGE) with 20/20 BioLabs, Inc. This potential merger is significant within the healthcare and biotechnology sectors, and Monteverde is keen to ensure that all shareholder rights are upheld.

The proposed agreement indicates that pre-merger stockholders of Longevity Health will retain an influential stake of approximately 49.9% in the newly formed entity. Given the complexities associated with mergers and acquisitions, Monteverde emphasizes the importance of shareholder awareness during this transitional period. With the firm’s commendable reputation as a top-tier class action firm, recognized in the 2024 ISS Securities Class Action Services Report, their involvement assures shareholders that their interests will be championed rigorously.

Monteverde & Associates boasts a successful track record in recovering millions for shareholders, which positions them as a formidable entity in shareholder advocacy. Their offices in the Empire State Building have become synonymous with strategic legal action aimed at protecting equity holders. The firm urges shareholders of Longevity Health Holdings to remain vigilant and proactive regarding their investments, especially in light of significant corporate developments such as this merger.

The firm is offering consultations free of charge, which includes no obligations or costs to shareholders seeking clarity about their rights and the details surrounding the merger. In conjunction with their ongoing investigation, Monteverde encourages shareholders to inquire about past recoveries, demonstrating the firm’s capability in effectively litigating cases similar to their current investigation.

As a national class action securities firm, Monteverde has established itself in trial courts and appellate courts, including precedents set in the U.S. Supreme Court. Their commitment to accountability ensures no company, director, or officer is immune from legal scrutiny. Thus, shareholders associated with Longevity Health Holdings, particularly those with reservations or uncertainties regarding the merger, are advised to reach out for more information.

To connect with Monteverde:

• - Email: [email protected]
• - Phone: (212) 971-1341
• - Address: Monteverde & Associates PC, The Empire State Building, 350 Fifth Ave. Suite 4740, New York, NY 10118, USA.

In light of this merger investigation, it becomes paramount for stakeholders to understand the implications of the merger on their equity. The opportunity to engage with seasoned legal representatives like Monteverde can provide a significant advantage in navigating the complexities of this merger and protecting one's investments. The result of this ongoing investigation could potentially shape the future of Longevity Health and its shareholders, underlining the inevitable intertwining of legal actions, regulatory scrutiny, and corporate strategies in the contemporary business landscape.

For more comprehensive information regarding this case, shareholders are encouraged to visit Monteverde's official site. Maintaining a watchful eye during transitional periods in corporate developments proves essential for safeguarding shareholder rights and capital.

Conclusion

This merger presents an array of potential opportunities and challenges for shareholders of Longevity Health Holdings. As Monteverde & Associates PC continues its investigation, the emphasis on shareholder protection remains a testament to the firm's dedication to justice and the responsible management of corporate mergers in the health industry.